<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00344695</url>
  </required_header>
  <id_info>
    <org_study_id>3R01CA077081-04S1</org_study_id>
    <nct_id>NCT00344695</nct_id>
  </id_info>
  <brief_title>Bupropion Treatment for Youth Smoking Cessation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arizona</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to 1) evaluate the safety and efficacy of two doses of bupropion&#xD;
      SR (150mg/day and 300mg/day) when compared to placebo, as an aid to smoking cessation in&#xD;
      adolescents and 2) to examine which factors, such as medication adherence, nicotine&#xD;
      dependence, and motivation to quit, affect treatment outcome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <completion_date>April 2003</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biochemically verified 7 day point prevalence abstinence from smoking.</measure>
  </primary_outcome>
  <condition>Nicotine Dependence</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupropion SR</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  14 to 17 years of age&#xD;
&#xD;
          -  Smoked at least 6 cigarettes per day&#xD;
&#xD;
          -  Exhaled CO greater than or equal to 10 ppm&#xD;
&#xD;
          -  Made at least two previous quit attempts&#xD;
&#xD;
          -  Weighed at least 90 pounds&#xD;
&#xD;
          -  Able to read English at least the 6th grade level&#xD;
&#xD;
          -  Motivated to quit smoking as evidenced by willingness to commit to study protocol&#xD;
             requirements for the duration of the study&#xD;
&#xD;
          -  provided active parental consent and youth assent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current use of tobacco products other than cigarettes, unless willing to abstain from&#xD;
             these products for the study duration&#xD;
&#xD;
          -  Current use of other treatments for smoking cessation&#xD;
&#xD;
          -  History or current diagnosis of panic disorder, psychosis, bipolar disorder, or eating&#xD;
             disorder&#xD;
&#xD;
          -  History of abuse or dependence on alcohol or other recreational or prescription drugs&#xD;
             in the three months preceding the study&#xD;
&#xD;
          -  Current evidence of clinical depression or Attention Deficit/Hyperactivity Disorder&#xD;
&#xD;
          -  Use of any psychoactive drug and/or any type of antidepressant with in four weeks of&#xD;
             the treatment phase of the study&#xD;
&#xD;
          -  Predisposition to seizure or tic disorders or a personal history of a seizure&#xD;
             disorder, family history of seizure disorders, or treatment with medication or&#xD;
             therapies that increase the risk of seizures&#xD;
&#xD;
          -  Significant history of or current clinical evidence of cardiovascular disease&#xD;
&#xD;
          -  (Females)Pregnancy (urine pregnancy test), lactation or, if sexually active,&#xD;
             unwillingness to use a medically acceptable form of contraception for the duration of&#xD;
             the study&#xD;
&#xD;
          -  Only one member of a household was allowed to participate in the study concurrently.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myra L. Muramoto, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arizona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2006</verification_date>
  <study_first_submitted>June 23, 2006</study_first_submitted>
  <study_first_submitted_qc>June 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2006</study_first_posted>
  <last_update_submitted>June 23, 2006</last_update_submitted>
  <last_update_submitted_qc>June 23, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupropion</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

